A similar percentage of women gave CD8+ T-cell responses in each patient group: no CIN (75%; nine out of 12), low-grade disease (75%; six out of eight), high-grade disease (69%; 11 out of 16) and cervical cancer (80%; four out of five) (Figure 2C). The gene discussed is CD8A; the disease is cervical carcinoma.